Close

Drug Research

Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories...

BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer

BioNTech SE and Medigene AG, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. The initial term...

Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility

Northwest Biotherapeutic, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its recently licensed production facility in Sawston, UK. This...

BioGenes, Alphalyse partner to optimize ELISA reagent characterization for biomanufacturing

BioGenes has partnered with Alphalyse, a specialist contract research organization. Recently, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years have partnered up to offer their respective methods to biologics...

Berkshire Sterile to offer formulation, lyophilization, and method development services

Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions. BSM will now offer first-in-human formulation development, supply material for preclinical studies,...

Seqirus Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology

Seqirus, a global leader in influenza prevention and a business of CSL Limited announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company’s growing R&D portfolio, with...

Piramal Pharma Solutions Strengthens UK Presence with the Expansion and Upgrade of its Grangemouth and Morpeth Facilities

Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read